PEPFAR Funding by HIV Prevalence

Although PEPFAR is focused on low- and middle-income countries with a high burden of HIV, PEPFAR funding provides support for the response to HIV to countries with a wide range of epidemiological profiles and HIV/AIDS prevalence levels. The committee used 2009 prevalence to group the 31 countries that were the focus of this evaluation into three categories; this year was chosen because it represented the most complete year for which prevalence data were available, and few countries would shift categories if another year were used. Information about PEPFAR’s approved funding over time in these prevalence groupings is shown in Figure 4-16 and Table 4-3. Almost all PEPFAR-approved funding (95 percent) over the FY 2005–2011 period went to countries with high HIV prevalence (>1 percent of the general population). From FY 2005 to FY 2011 the greatest share of PEPFAR funding (60 percent) was approved for 16 countries with adult HIV prevalence rates between 1 and 10 percent. During the same time period PEPFAR funded nine countries with prevalence rates of 10 percent or greater; this subset of countries received approximately one-third of total funding (35 percent) and also had the highest median funding level and included the highest maximum in the range of funding per country. Six countries with national prevalence rates below 1 percent received 5 percent of total funding (OGAC, 2005, 2006b, 2007c, 2008c, 2010e, 2011c,d). Globally, there were nine countries with HIV prevalence rates greater than


FIGURE 4-16 PEPFAR planned/approved funding by 2009 prevalence groupings in 31 PEPFAR partner countries (current USD millions).
SOURCES: OGAC, 2005, 2006b, 2007c, 2008c, 2010e, 2011c,d.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement